[HTML][HTML] The multiple faces of the metal transporter ZIP14 (SLC39A14)
TB Aydemir, RJ Cousins - The Journal of nutrition, 2018 - Elsevier
The SLC39A family of metal transporters was identified through homologies with the Zrt-and
Irt-like (ZIP) proteins from yeast and plants. Of all the ZIP transporters, ZIP14 is arguably the …
Irt-like (ZIP) proteins from yeast and plants. Of all the ZIP transporters, ZIP14 is arguably the …
[HTML][HTML] Long non-coding RNAs are involved in alternative splicing and promote cancer progression
J Ouyang, Y Zhong, Y Zhang, L Yang, P Wu… - British Journal of …, 2022 - nature.com
Alternative splicing (AS) is a key process in which precursor RNAs produce different mature
RNAs, and the disorder of AS is a key factor in promoting cancer development. Compared …
RNAs, and the disorder of AS is a key factor in promoting cancer development. Compared …
[PDF][PDF] Transcriptome‐wide analysis reveals the landscape of aberrant alternative splicing events in liver cancer
Alternative splicing (AS) is assumed to be a pivotal determinant for the generation of diverse
transcriptional variants in cancer. However, the comprehensive dysregulation of AS and the …
transcriptional variants in cancer. However, the comprehensive dysregulation of AS and the …
[HTML][HTML] Recent advances in the role of SLC39A/ZIP zinc transporters in vivo
Zinc (Zn), which is an essential trace element, is involved in numerous mammalian
physiological events; therefore, either a deficiency or excess of Zn impairs cellular …
physiological events; therefore, either a deficiency or excess of Zn impairs cellular …
[HTML][HTML] Alternative splicing in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancer cases, with
more than 850,000 new diagnoses per year globally. Recent trends in the United States …
more than 850,000 new diagnoses per year globally. Recent trends in the United States …
[HTML][HTML] SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma
S Yang, R Jia, Z Bian - Biochimica et Biophysica Acta (BBA)-Molecular Cell …, 2018 - Elsevier
Alternative splicing of precursor messenger RNA has been increasingly associated with
tumorigenesis. The serine/arginine-rich protein (SR) family plays key roles in the regulation …
tumorigenesis. The serine/arginine-rich protein (SR) family plays key roles in the regulation …
[HTML][HTML] Celf family proteins in cancer: Highlights on the rna-binding protein/noncoding rna regulatory axis
M Nasiri-Aghdam, TC Garcia-Garduño… - International journal of …, 2021 - mdpi.com
Post-transcriptional modifications to coding and non-coding RNAs are unquestionably a
pivotal way in which human mRNA and protein diversity can influence the different phases …
pivotal way in which human mRNA and protein diversity can influence the different phases …
[HTML][HTML] Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC)
Y Dong, L Xue, Y Zhang, C Liu, Y Zhang… - Journal of Experimental …, 2022 - Springer
Background Oral squamous cell carcinoma (OSCC) is one of the common cancers
worldwide. The lack of specific biomarkers and therapeutic targets leads to delayed …
worldwide. The lack of specific biomarkers and therapeutic targets leads to delayed …
[HTML][HTML] The more the merrier—complexity in long non-coding rna loci
C Ziegler, M Kretz - Frontiers in endocrinology, 2017 - frontiersin.org
One of the long-standing principles of molecular biology has been that DNA functions as a
template for transcription of messenger RNAs, which are eventually translated into a protein …
template for transcription of messenger RNAs, which are eventually translated into a protein …
[HTML][HTML] A cell-to-patient machine learning transfer approach uncovers novel basal-like breast cancer prognostic markers amongst alternative splice variants
JP Villemin, C Lorenzi, MS Cabrillac, A Oldfield… - BMC biology, 2021 - Springer
Background Breast cancer is amongst the 10 first causes of death in women worldwide.
Around 20% of patients are misdiagnosed leading to early metastasis, resistance to …
Around 20% of patients are misdiagnosed leading to early metastasis, resistance to …